GPOs Rethink Diagnostics
Executive Summary
As major GPOs come under pressure from a variety of sources they are refining their approach to laboratory purchasing, with ramifications for suppliers. Groups are getting tougher on compliance and contracting with fewer lab vendors but the trade-off is less choice for lab members. The more the purchasing process restricts vendors, the more it benefits a few at the expense of many.
You may also be interested in...
The State of Laboratory Unions
Hospital laboratory consolidation, underway for several years, is having mixed success as the market shifts. For suppliers, things are unlikely to settle down soon. Successful labs claim to be committed to a common vision and to swift action to institute painful changes. But other labs are stymied by politics, lack of top management support, and reluctance to make difficult decisions quickly. Manufacturers' expectations that consolidation would lead to standardization of equipment and a winner-take-all mentality are starting to come to pass. But the customer base continues to be in more flux than expected.
In Case You Missed It: China’s ‘Dual Circulation’ Policy, Fixing Safety Data ‘Overload,’ And More
We clean out your Thanksgiving inbox so you don't have to.
US FDA’s Comirnaty Review By The Numbers
A timeline of the review and development of the first COVID-19 vaccine to win BLA approval.